AKT1 and neoplasm: Temsirolimus is an mTOR inhibitor that inhibits the phosphoinositide 3-kinase (PI3K)/Protein kinase B (AKT)/mTOR pathway, which is involved in protein synthesis, cellular proliferation, and tumor angiogenesis [10, 11].